GCA
LLY icon

Gallagher Capital Advisors’s Eli Lilly LLY Stock Holding History

Gallagher Capital Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.09M Buy
1,808
+2
+0.1% +$2.36K 1.12% 29
2026
Q2 		$2.17M Sell
1,806
-8
-0.4% -$8.17K 1.24% 26
2026
Q1 		$1.67M Sell
1,814
-54
-3% -$54.7K 1.09% 29
2025
Q4 		$2.01M Sell
1,868
-2
-0.1% -$1.91K 1.3% 27
2025
Q3 		$1.64M Buy
1,870
+126
+7% +$93.8K 0.95% 27
2025
Q2 		$1.35M Buy
1,744
+1,335
+326% +$1.04M 1.09% 30
2025
Q1 		$338K Buy
409
+1
+0.2% +$832 0.26% 50
2024
Q4 		$315K Buy
+408
New +$338K 0.23% 52

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Gallagher Capital Advisors's LLY Position: Q3 2026 in Review

Gallagher Capital Advisors increased its Eli Lilly (LLY) stake by 0.11% in Q3 2026, buying an estimated $2.36K and bringing the position to 1,808 shares worth $2.09M. The position accounts for 1.12% of the portfolio, ranked #29.

Gallagher Capital Advisors first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. The position peaked at $2.17M in Q2 2026. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Gallagher Capital Advisors held 1,808 shares of Eli Lilly worth $2.09M as of Q3 2026.
  • Gallagher Capital Advisors bought 2 Eli Lilly shares in Q3 2026, an estimated $2.36K.
  • Eli Lilly made up 1.12% of Gallagher Capital Advisors's portfolio in Q3 2026, its #29 holding.
  • Gallagher Capital Advisors first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
  • Gallagher Capital Advisors's Eli Lilly position peaked at $2.17M in Q2 2026.
  • 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Gallagher Capital Advisors's 13F filing for Q3 2026, filed 9 Oct 2026.